Can Smartphone-Based oximeters save kids with pneumonia?

NCT ID NCT05914324

Ongoing Knowledge-focused Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing two new types of pulse oximeters—simple devices that measure oxygen levels—for babies and toddlers with pneumonia in Cape Town, South Africa. Researchers want to see if these devices help healthcare workers correctly identify children with low oxygen and refer them for care. About 936 children under 2 years old will take part, and the goal is to improve pneumonia management in low-resource settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Phefumla device and LB-01 device (pulse oximeters)
What this could lead to: If successful, this could show that affordable, easy-to-use pulse oximeters help healthcare workers correctly identify and refer children with dangerously low oxygen levels, potentially reducing deaths from pneumonia in low-resource settings.
What could go wrong: This is an observational/device evaluation study, not a treatment trial. The devices may not perform as well as expected in real-world conditions, and results may not apply to other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypoxia primary interstitial lung disease specific to childhood respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILD HYPOXIA INFANT RESPIRATORY TRACT INFECTIONS

Contacts and locations

Locations

Desmond Tutu TB Centre

Cape Town, Western Cape, 7505, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.